发明授权
- 专利标题: Intracorporeal medicaments for photodynamic treatment of disease
- 专利标题(中): 用于光动力治疗疾病的体内药物
-
申请号: US12150330申请日: 2008-04-25
-
公开(公告)号: US07863047B2公开(公告)日: 2011-01-04
- 发明人: H. Craig Dees , Timothy C. Scott , Eric A. Wachter , Walter G. Fisher , John Smolik
- 申请人: H. Craig Dees , Timothy C. Scott , Eric A. Wachter , Walter G. Fisher , John Smolik
- 申请人地址: US TN Knoxville
- 专利权人: Provectus Pharmatech, Inc.
- 当前专利权人: Provectus Pharmatech, Inc.
- 当前专利权人地址: US TN Knoxville
- 代理机构: Husch Blackwell LLP Welsh Katz
- 主分类号: A61K51/00
- IPC分类号: A61K51/00 ; A61K49/00 ; A61M36/14 ; G01N23/00
摘要:
New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.